Tocilizumab as a Potential Adjunctive Therapy to Corticosteroids in Cryptococcal Post-infectious Inflammatory Response Syndrome (PIIRS): a Report of Two Cases

Balasko A(2019)Shedding light on IRIS: from pathophysiology to treatment of cryptococcal meningitis and immune reconstitution inflammatory syndrome in HIV-infected individuals HIV Med. 20 1-10

Keynan Y(2013)Predictors of mortality and differences in clinical features among patients with cryptococcosis according to immune status PLoS One. 8 e60431-e2e98

Brizendine KD(2015)Paradoxical immune responses in non-HIV cryptococcal meningitis PLoS Pathog. 11 e1004884-1925

Baddley JW(2021)Outcomes in previously healthy cryptococcal meningoencephalitis patients treated with pulse taper corticosteroids for post-infectious inflammatory syndrome Clin Infect Dis. 73 e2789-42

Pappas PG(2022)Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of post-infectious inflammatory response syndrome Front Neurol. 13 994396-16

Panackal AA(2018)Prednisone for the prevention of paradoxical tuberculosis-associated IRIS N Engl J Med. 379 1915-20

Wuest SC(2022)The role of IL-6 in coronavirus, especially in COVID-19 Front Pharmacol. 13 1033674-e00913

Lin YC(2018)A review of recent advances using tocilizumab in the treatment of rheumatic diseases Rheumatol Ther. 5 21-3966

Wu T(2021)Tocilizumab in hospitalized patients with severe COVID-19 pneumonia N Engl J Med. 384 1503-3709

Zhang N(2015)Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis Ann Neurol. 78 3-104

Balasko A(2019)Shedding light on IRIS: from pathophysiology to treatment of cryptococcal meningitis and immune reconstitution inflammatory syndrome in HIV-infected individuals HIV Med. 20 1-10

Keynan Y(2013)Predictors of mortality and differences in clinical features among patients with cryptococcosis according to immune status PLoS One. 8 e60431-e2e98

Brizendine KD(2015)Paradoxical immune responses in non-HIV cryptococcal meningitis PLoS Pathog. 11 e1004884-1925

Baddley JW(2021)Outcomes in previously healthy cryptococcal meningoencephalitis patients treated with pulse taper corticosteroids for post-infectious inflammatory syndrome Clin Infect Dis. 73 e2789-42

Pappas PG(2022)Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of post-infectious inflammatory response syndrome Front Neurol. 13 994396-16

Panackal AA(2018)Prednisone for the prevention of paradoxical tuberculosis-associated IRIS N Engl J Med. 379 1915-20

Wuest SC(2022)The role of IL-6 in coronavirus, especially in COVID-19 Front Pharmacol. 13 1033674-e00913

Lin YC(2018)A review of recent advances using tocilizumab in the treatment of rheumatic diseases Rheumatol Ther. 5 21-3966

Wu T(2021)Tocilizumab in hospitalized patients with severe COVID-19 pneumonia N Engl J Med. 384 1503-3709

Zhang N(2015)Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis Ann Neurol. 78 3-104